Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 May;50(5):1893-5.
doi: 10.1128/AAC.50.5.1893-1895.2006.

Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic

Affiliations

Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic

Christian Dokomajilar et al. Antimicrob Agents Chemother. 2006 May.

Abstract

Polymorphisms in the Plasmodium falciparum pfmdr1 gene were assayed in pretreatment samples and in samples from patients reinfected following therapy with artemether-lumefantrine. The pfmdr1 alleles 86N, 184F, and 1246D significantly increased in prevalence after treatment. All samples had a single pfmdr1 copy. Treatment with artemether-lumefantrine selects for polymorphisms that may alter antimalarial drug response.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Prevalence of pfmdr1 alleles in pretreatment samples and samples from newly infected patients following therapy with artemether-lumefantrine. Alleles typically classified as wild type are on the left, mixed infections are in the middle, and those classified as mutant are on the right.

References

    1. Bukirwa, H., A. Yeka, M. R. Kamya, A. Talisuna, K. Banek, N. Bakyaita, J. B. Rwakimari, P. J. Rosenthal, F. Wabwire-Mangen, G. Dorsey, and S. G. Staedke. Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda. PLoS Clin. Trials, in press. - PMC - PubMed
    1. Cattamanchi, A., D. Kyabayinze, A. Hubbard, P. J. Rosenthal, and G. Dorsey. 2003. Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp. Am. J. Trop. Med. Hyg. 68:133-139. - PubMed
    1. Cravo, P. V., J. M. Carlton, P. Hunt, L. Bisoni, R. A. Padua, and D. Walliker. 2003. Genetics of mefloquine resistance in the rodent malaria parasite Plasmodium chabaudi. Antimicrob. Agents Chemother. 47:709-718. - PMC - PubMed
    1. Duraisingh, M. T., P. Jones, I. Sambou, L. von Seidlein, M. Pinder, and D. C. Warhurst. 2000. The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. Mol. Biochem. Parasitol. 108:13-23. - PubMed
    1. Duraisingh, M. T., C. Roper, D. Walliker, and D. C. Warhurst. 2000. Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum. Mol. Microbiol. 36:955-961. - PubMed

Publication types

MeSH terms

LinkOut - more resources